-
Landscape Review of Patient Engagement in the Health Technology Assessment (HTA) Process in Latin America
Mar 10, 2025, 14:00 PM -
Travel Burden of Beta-Thalassemia Patients Receiving Red Blood Cell Transfusions in the Brazilian Public Healthcare System: A Real-World Study
Mar 10, 2025, 14:00 PM -
Incidence, Prevalence, and Risk Factors of Giant Cell Arteritis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Pre-Diagnostic Healthcare for People with Fragile X Syndrome
Mar 10, 2025, 14:00 PM -
Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)
Mar 10, 2025, 14:00 PM -
Timing of Health Technology Assessment in the United States: An Evaluation of ICER Reviews Over Seven Years
Mar 10, 2025, 14:00 PM -
Estimated Public Health Impact of Adjuvanted RSVPreF3 Vaccination in US Adults Aged 18-49 Years Who Are at Increased Risk for Severe RSV Disease
Mar 10, 2025, 14:00 PM -
An Illustration of the Impact of Confounding Bias On Economic Evaluations in the Context of Real-World Evaluations
Mar 10, 2025, 14:00 PM -
Drivers of High ICERs in SMC Appraisals
Mar 10, 2025, 14:00 PM -
A Systematic Literature Review and Meta-Analysis Comparing Benign Robotic-Assisted Inguinal Hernia Repair Using the da Vinci Surgical Systems to Laparoscopic or Open Approach
Mar 10, 2025, 14:00 PM -
Clinical Validation of Large Language Model for Automated Extraction of Genetic Testing Data
Mar 10, 2025, 14:00 PM -
Analytical Approaches to Estimate Medication Persistence From Electronic Health Record Data: A Study of Tyrosine Kinase Inhibitors in Patients With Epidermal Growth Factor Receptor-Positive Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Hypophosphatasia (HPP) Patient & Caregiver Disease Burden, Quality of Life & Treatment Experience: A Mixed Methods Study Concept
Mar 10, 2025, 14:00 PM -
A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization in Patients with Idiopathic Pulmonary Fibrosis initiating Antifibrotic Therapy in the Medicare Fee-For-Service Population
Mar 10, 2025, 14:00 PM -
Early Health Outcomes Model on the Impact of Trimodulin in the Management of Patients With Severe Community-Acquired Pneumonia on Invasive Mechanical Ventilation Based on the CIGMA Phase 2 Randomized Placebo-Controlled Trial
Mar 10, 2025, 14:00 PM -
US Stakeholder Perspectives on Accumulators, Maximizers, and Alternative Funding Programs: Implications for Patient Affordability and Outcomes Research
Mar 10, 2025, 14:00 PM -
Associations Between Post-Diagnostic Statin Use, Cholesterol Levels, and Mortality Risk Among American Breast Cancer Patients: Insights from the National Health and Nutrition (NHANES) Survey
Mar 10, 2025, 14:00 PM -
Comparative Efficacy of First-Line Chemotherapies for Metastatic Pancreatic Cancer (mPC) Using Bayesian Network Meta-Analysis (Nma) of Survival Curves
Mar 10, 2025, 14:00 PM -
Seasonal Variation in Incidence and Outcomes of Hospitalizations with Severe Community-Acquired Bacterial Pneumonia in the U.S., 2018-2022
Mar 10, 2025, 14:00 PM
